Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Karolinska Development in connection with the company's listing on NASDAQ OMX
Mandate

Vinge advises Karolinska Development in connection with the company's listing on NASDAQ OMX

March 31, 2011

Vinge advises Karolinska Development AB (publ) in connection with the company’s new issue of shares of series B and listing of shares of series B on NASDAQ OMX Stockholm. First day of trading is expected to be 15 April 2011.

Vinge’s team consists of partner in charge Pontus Enquist as well as Emil Hedberg and Christoffer Benninge. In addition, Maria Schultzberg, Johanna Bergström and Maria Doeser (tax) as well as Claes Henriksson (IP), among other, have participated.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025